MEDICAL RESEARCH NETWORK LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +2.3%

  £45,755,178 → £46,817,009

  highest in 4 filed years

• Cash

  -56.3%

  £2,070,945 → £905,387

• Net assets

  -88%

  -£589,760 → -£1,109,023

  lowest in 4 filed years

• Employees

  -23.5%

  179 → 137

• Operating profit

  +98.2%

  -£5,107,192 → -£90,926

• Profit before tax

  +99.7%

  -£4,976,750 → -£13,825

• Wages

  -14.2%

  £11,232,281 → £9,639,088

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Azets Audit Services

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“At the time of approving the financial statements, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future, being at least 12 months from the approval of the financial statements. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements. The group's invoice discounting facility is due for renewal in November 2025, but having received an offer for extension and performed due diligence on the potential for alternative sources of funding, the directors are confident in the availability of financing to fulfil the group's ambitions and obligations. Based on the modelling work performed and stress-testing MRN's financial forecasts, the directors assert that the group remains a going concern for the period under review, and that there are no material uncertainties present.”

Significant events

• “After the reporting date, the company initiated a strategic restructuring process aimed at enhancing operational efficiency and long-term growth. As part of this initiative, a redundancy programme was announced in June 2025, affecting 16 roles. The total cost of he redundancy was £238,000 with an annualised costs saving of £891,000.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.